Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_assertion type Assertion NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_head.
- NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_assertion wasGeneratedBy ECO_0000203 NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_provenance.
- NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_assertion wasDerivedFrom befree-20150227 NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_provenance.
- NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_assertion SIO_000772 10545285 NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_provenance.
- NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_assertion evidence source_evidence_literature NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_provenance.
- NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_assertion description "[If BLP ligand-receptor systems are to be targeted therapeutically in NSCLC, it will be necessary to inhibit both NMB and GRP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_provenance.